Characterisation of a hydroxymandelate oxidase involved in the biosynthesis of two unusual amino acids occurring in the vancomycin group of antibiotics
Chemical Communications2001Iss. 18, pp. 1752–1753
Citations Over Time
Tsung‐Lin Li, Oliver W. Choroba, Elizabeth H. Charles, Alan M. Sandercock, Dudley H. Williams, Jonathan B. Spencer
Abstract
ORF22 from the chloroeremomycin gene cluster has been cloned, expressed and characterised as a hydroxymandelate oxidase (HmO) that is involved in the formation of both (S)-4-hydroxyphenylglycine and (S)-3,5-dihydroxyphenylglycine.
Related Papers
- → Does Intrawound Vancomycin Application During Spine Surgery Create Vancomycin-Resistant Organism?(2017)72 cited
- → Controlling the Evolution of Selective Vancomycin Resistance through Successful Ophthalmic Eye-Drop Preparation of Vancomycin-Loaded Nanoliposomes Using the Active-Loading Method(2023)21 cited
- → Vancomycin Revisited: A Reappraisal of Clinical Use(2008)38 cited
- → Do Dose-Dependent Microbial Changes Occur during Spine Surgery as a Result of Applying Intrawound Vancomycin Powder?: A Systematic Literature Review(2018)20 cited
- → Serum and Synovial Vancomycin Concentrations in Patients with Prosthetic Joint Infection after Intra-articular Infusion(2021)18 cited